Vaccine formulations
US7371395B2 · kind B2 · utility
56Cited by
3References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2004 |
| Grant date | May 13, 2008 |
| Priority date | — |
| Expiry date | Oct 31, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified or weakly purified. The emulsion of the present invention can act as vehicle for the delivery of a pharmaceutical composition comprising at least one immunogen and, in particular, an immunogen selected from the group comprising an inactivated pathogen, an attenuated pathogen, a subunit, a recombinant expression vector, and a plasmid or combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.